U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07249554) titled 'Combination Therapy for Alcohol Use Disorder' on Nov. 18.
Brief Summary: This human laboratory study will collect preliminary safety and efficacy data from a sample of participants enrolled in a 4-week in-patient treatment program for alcohol use disorder.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Alcohol Use Disorder
Intervention:
DRUG: Placebo
Over-encapsulated non-active microcrystalline cellulose
DRUG: Glucagon-Like Peptide-1 Agonist (GLP-1)
Over-encapsulated Glucagon-Like Peptide-1 Agonist (GLP-1) oral tablets
DRUG: Naltrexone (oral tablets)
Over-encapsulated Naltrexone (oral tablets)
Recru...